Fig. 6.
Percentage of ClinSeq®CACNA1S variants, class 1–5. Proportion of 51 CACNA1S variants from the ClinSeq® 870 cohort in pathogenicity classes 1 through 5. (ClinSeq® trademark held by National Institutes of Health, Bethesda, MD.)
Percentage of ClinSeq®CACNA1S variants, class 1–5. Proportion of 51 CACNA1S variants from the ClinSeq® 870 cohort in pathogenicity classes 1 through 5. (ClinSeq® trademark held by National Institutes of Health, Bethesda, MD.)
